Drug & medication recalls Moderate risk

Fentanyl citrate recalled over manufacturing violations

Recall date
September 23, 2025
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Park Avenue Compounding recalls Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662…
Recall number
D-0178-2026
FDA classification
Class II
Brand / firm
Park Avenue Compounding
Sold / distributed
Distributed in Missouri

Why it was recalled

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.

Get recall alerts

Free email alert whenever Park Avenue Compounding has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Park Avenue Compounding